Endlyz Therapeutics, Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Endlyz Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (May 2026).
SEC Form D · May 2026
The industry group it chose in its notices: Biotechnology.
SEC Form D · May 2026
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Endlyz Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Joanna Wolak | Executive officer | May 2026 |
| Zaven Kaprielian | Executive officer | Jul 2021 |
| Donmienne Leung | Director | May 2026 |
| Joanna Wolak | Director | May 2026 |
| Justian Craig Fox | Director | May 2026 |
| Laurence Barker | Director | May 2026 |
| Timothy Edwards | Director | May 2026 |
| Damian Crowther | Director | Jul 2021 |
| John Gustofson | Director | Jul 2021 |
| Jonathan Behr | Director | Jul 2021 |
| Zaven Kaprielian | Director | Jul 2021 |